Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subjects: Photo/Multimedia, Product/Service, Webcast

Bruker Highlights New Analytical Systems and Applied Market Solutions


Bruker Corporation (Nasdaq: BRKR) this week highlights new analytical systems and high-value solutions for biopharma and forensics applications, as well as for industrial process control and materials science research. Originally, Bruker had planned to launch these products at Analytica 2020 this week. However, with conferences and tradeshows postponed or cancelled due to COVID-19, Bruker remains committed to the success of its customers, and is proceeding with on-line launches at this time.

OMEGA 5 FTIR Gas Analyzer: OMEGA 5 is a new Fourier Transform Infrared (FTIR) gas analyzer that is rackmounted and equipped with a multi-reflection gas cell of 5 m optical path length. It allows automated, precision and real-time monitoring of gas concentrations even in mixtures. The OMEGA 5 is designed for applications like process monitoring, the investigation of catalytic processes, or the determination of gas impurities. More info

FOURIERtm CrimeLab ? Benchtop FT-NMR for Forensic Laboratories: Bruker envisions that interconnected high-field NMR spectrometers at central forensic laboratories and benchtop FOURIER CrimeLab 80 MHz FT-NMRs at local labs will enable law enforcement to unambiguously identify suspicious known or new psychoactive substances. Benchtop FT-NMR is made easy for novices by the new push-button, non-expert software GoScan. Please watch our recorded webinar

S2 PUMAtm - Benchtop X-Ray Elemental Analyzer: the next-generation benchtop Energy Dispersive X-Ray Fluorescence (EDXRF) spectrometer S2 PUMATM Series 2 is equipped with HighSenseTM technology for increases in throughput by about a factor of 3x. Bruker's software SPECTRA.ELEMENTSTM comes with enhanced features and faster algorithms, leading to ~40% shorter evaluation times. The S2 PUMA Series 2 supports elemental analysis applications from cement, steel, mining and petrochemical, to food analysis and pharma QC. The new mapping stage also extends its applications into semiconductors and coatings, where spatial resolution is required. Please watch our recorded webinar

Sierra SPR-24 Pro ? Biopharma ?Workhorse': Bruker expands its Surface Plasmon Resonance (SPR) product line with the Sierra SPR-24 Pro, which complements the highest-performance Sierra SPR-32. The new, robust SPR-24 Pro offers high performance and throughput for biopharma applications such as antibody characterization, protein-protein and protein-small molecule interactions, fragment screening, etc. It offers an 8-channel, 3-sensor-spot design (i.e. 24 addressable spots) with automated operation by robotic plate handling for further increases in SPR throughput. Please watch our upcoming webinar

Other on-demand and upcoming webinars on a wide range of applications can be can be found at www.bruker.com/webinars

About Bruker Corporation (Nasdaq: BRKR)

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology. For more information, please visit: www.bruker.com.


These press releases may also interest you

at 02:05
PureTech Health plc ("PureTech" or the "Company") plans to publish its Annual Report and Accounts and financial results for the year ended December 31, 2023, on Thursday, April 25, 2024. A presentation and conference call to discuss the results...

at 02:05
Hansa Biopharma, the pioneer in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced its business update and year-end report for January to March 2024. Highlights for the first quarter of 2024      Strong commercial...

at 01:30
The shares in Aker ASA will be traded ex-dividend NOK 15.50 as from today, 18 April 2024. Investor contact:Fredrik Berge, Head of Investor Relations Aker ASA Tel: +47 450 32 090 E-mail: [email protected] Media contact:Atle Kigen, Head of...

at 00:00
Health Carousel, renowned for its dedication to enhancing the healthcare staffing sector, today unveiled its groundbreaking 'Full Circle of Support' program. This initiative represents a significant investment in the total well-being of its...

17 avr 2024
TaiGen Biotechnology Company, Limited ("TaiGen") announces today that the business partner, Joincare Pharmaceutical, has completed the unblinding of influenza antiviral TG-1000 phase III study. Preliminary data shows that the median time to...

17 avr 2024
SysInformation Healthcare Services, LLC ("SysInformation"), d/b/a EqualizeRCM and 1st Credentialing, is providing notice of a recent data security event that may affect the security of information related to certain individuals. SysInformation is...



News published on and distributed by: